TrialInternational journal of clinical oncology2020

Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumab.

Kotaro Suzuki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.